Optimization of bicycle Ergometer training

Refonet (Germany)0 个研究点目标入组 340 人开始时间: 2006年8月31日最近更新: 2015年1月13日

试验速览

暂无简介。

•1. Angiographic proved coronary disease
•2. Echocardiogram (ECG) proved normal or slightly limited systolic cardiac function
•3. Angina pectoris or acute coronary syndrome more than or equal to ten days before joining the research project
•4. Sinus rhythm

•1. Acute coronary syndrome less than ten days before joining the research project
•2. Moderate to severe limited sysolic cardiac function
•3. Aorto-coronary bypass operation more than or equal to three months before joining the research project
•4. Atrial fibrillations or therapy relevant ventricular arrythmia
•5. Clinically limiting peripheral arterial disease
•6. Present hypertrophic obstructive cardiac myopathy
•7. Non-regulatable arterial hypertonia
•8. Haemodynamically relevant cardiac valvular defect
•9. Pericarditis, myocarditis and lung embolic more than or equal to six months before joining the research project
•10. Limiting orthopaedic secondary disorders
•11. Consuming and intercurrent diseases
•12. Renal insufficiency (Creatinine > 2.0 mg/dl)
•13. Anaemia (haemoglobin [Hb] < 12g/dl)
•14. Severe chronic obstructive pulmonary disease (Forced Expiratory Volume in one second [FEV1] < 35%)
•15. Respiratory global insufficiency
•16. Implantable Cardioverter Defibrillator (ICD) implantation

发起方

Refonet (Germany)